KEIFEI Advanced Semaglutide Pen for Glycemic Control & Satiety
Semaglufei Pen contains 16.25mg of Semaglutide, a highly effective GLP-1 receptor agonist that optimizes insulin secretion, reduces hepatic glucose and delays digestion to promote prolonged fullness. This once-weekly, pre-filled disposable pen supports clinical weight loss and major cardiovascular risk management under professional medical guidance.
Advanced Weight & Glycemic Benefits
Enhanced Satiety
Slows gastric emptying to help you feel full longer, significantly reducing daily caloric appetite.
Optimized Insulin
Helps the pancreas produce insulin when blood sugar levels are high, stabilizing overall glycemic index.
Clinically Supported Weight Loss
Studies show patients on active Semaglutide lost significantly more weight compared to placebo groups.
Cardio Protection
Lower the risks of major cardiovascular events like heart attacks, stroke, or heart-related mortality.
Semaglufei Pen is intended for adults with Type 2 diabetes aiming to improve glycemic control and manage cardiovascular risks, as well as those seeking clinically proven appetite regulation for weight loss.